Grifols (GIFLF) Enterprise Value Growth (1y) (2011 - 2025)

Grifols (GIFLF) Enterprise Value Growth (1y) (2011 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Grifols - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 8.41%
Dec 31, 2024 -77.20%
Dec 31, 2023 1.66%
Dec 31, 2022 80.09%
Dec 31, 2021 -346.88%
Dec 31, 2020 10.14%
Sep 30, 2020 373.17%
Mar 31, 2020 475.36%
Dec 31, 2019 267.98%
Sep 30, 2019 58.33%
Mar 31, 2019 -38.36%
Dec 31, 2018 36.70%
Jun 30, 2018 5.15%
Mar 31, 2018 451.17%
Dec 31, 2017 -9.21%
Jun 30, 2017 10.60%
Mar 31, 2017 85.90%
Dec 31, 2016 22.91%
Sep 30, 2016 0.17%
Jun 30, 2016 -3.83%